UBS

UBS Group AG

UBS is a Swiss global bank and wealth manager headquartered in Zurich; its Investment Bank's Global Research unit covered over 3,800 stocks in 52 markets as of 2025 and is known for data products such as UBS Evidence Lab and HOLT.

Company history

UBS dates its founding to the Bank in Winterthur, established in 1862, which merged with Toggenburger Bank in 1912 to form Union Bank of Switzerland. Swiss Bank Corporation, which had bought S.G. Warburg in 1995, merged with Union Bank of Switzerland in 1998 to form UBS, which acquired PaineWebber in 2000. In June 2023 UBS completed the government-brokered takeover of Credit Suisse, keeping its HOLT valuation platform; it aims to substantially complete the integration by end-2026.

  1. 1862Bank in Winterthur, UBS's recognized first antecedent, founded
  2. 1912Merger with Toggenburger Bank formed Union Bank of Switzerland
  3. 1995Swiss Bank Corporation acquired London investment bank S.G. Warburg
  4. 1998Union Bank of Switzerland and Swiss Bank Corporation merged as UBS
  5. 2000Acquired US brokerage PaineWebber
  6. 2023Completed emergency takeover of Credit Suisse

Research

UBS Global Research had analysts in more than 20 countries covering over 3,800 stocks in 52 markets in 2025, and the bank lists about 720 analysts, strategists and economists. Fundamental coverage is paired with Quant Research, Evidence Lab alternative-data sets and the HOLT database of more than 20,000 company profiles. Stocks receive 12-month Buy, Neutral or Sell ratings set by forecast total return against a market return assumption (local one-year rate plus 5%), with occasional short-term calls.

Coverage12M

Stocks
1,712
Ratings
4,296
Price targets
4,250
Median upside
+15.1%
Upgrades
218
Downgrades
182
Initiations
89
Reiterations
3,807
Targets raised
2,136
Targets cut
1,409
  • Positive51%727
  • Neutral45%634
  • Negative4%59

Sectors

  • Health Care16%
  • Information Technology15%
  • Financials13%
  • Consumer Discretionary12%
  • Industrials11%
  • Other6%
  • Materials6%

Ratings

  • Buy49%
  • Neutral47%
  • Sell3%

Listing

  • United States79%
  • Canada2%
  • United Kingdom2%
  • China1%

Activity24M

RatingsPrice targets1,048
Oct 2024 · Ratings 186 · Price targets 51Nov 2024 · Ratings 176 · Price targets 28Dec 2024 · Ratings 84 · Price targets 18Jan 2025 · Ratings 236 · Price targets 28Feb 2025 · Ratings 250 · Price targets 22Mar 2025 · Ratings 162 · Price targets 70Apr 2025 · Ratings 386 · Price targets 65May 2025 · Ratings 373 · Price targets 66Jun 2025 · Ratings 112 · Price targets 21Jul 2025 · Ratings 473 · Price targets 86Aug 2025 · Ratings 367 · Price targets 112Sep 2025 · Ratings 166 · Price targets 115Oct 2025 · Ratings 470 · Price targets 552Nov 2025 · Ratings 312 · Price targets 186Dec 2025 · Ratings 170 · Price targets 303Jan 2026 · Ratings 353 · Price targets 536Feb 2026 · Ratings 271 · Price targets 462Mar 2026 · Ratings 241 · Price targets 113Apr 2026 · Ratings 346 · Price targets 240May 2026 · Ratings 384 · Price targets 422Jun 2026 · Ratings 220 · Price targets 268Jul 2026 · Ratings 571 · Price targets 477Aug 2026 · Ratings 587 · Price targets 433Sep 2026 · Ratings 345 · Price targets 230
Oct '24Oct '25Sep '26

Most covered24M

StockRatingTargetActionsLast action
HUBSHubSpot, Inc.Neutral$29035Sep 18
DALDelta Air Lines, Inc.Buy$9929Sep 10
MUMicron Technology, Inc.Buy$1,54028Aug 10
UALUnited Airlines Holdings, Inc.Buy$13727Sep 10
AMZNAmazon.com, Inc.Buy$20026Sep 17
ADBEAdobe Inc.Neutral$25525Sep 11
GOOGLAlphabet Inc.Buy$40025Jul 31
MRVLMarvell Technology, Inc.Buy$27525Aug 24
SSRMSSR Mining Inc.Buy$3925Jul 1
EXEExpand Energy CorporationBuy$12924Sep 14

Analysts24M

  • Joshua SpectorAMBP · DD · ECL90
  • Jay SoleNKE · ONON · TJX68
  • Timothy ArcuriAMAT · MRVL · TXN65
  • Peter GromFIZZ · SMG · CLX63
  • Manav GuptaVLO · BE · PSX52
  • Josh SilversteinEXE · MUR · AR52

Recent actions

StockRating actionRatingTargetDate
CoreWeave, Inc. Class A Common StockCRWVInitiateBuy$120Sep 22
PG&E CorporationPCGDowngradeNeutral$23$14Sep 22
Pilgrim's Pride CorporationPPCReiterateNeutralSep 22
Option Care Health, Inc.OPCHReiterateBuySep 22
CVS Health CorporationCVSReiterateBuySep 22
Johnson & JohnsonJNJReiterateBuySep 22
Moderna, Inc.MRNAReiterateNeutralSep 22
CRH plcCRHTarget$147$135Sep 22
Chord Energy CorporationCHRDTarget$189$184Sep 22
Amrize LtdAMRZTarget$52$42Sep 22

Similar coverage12M

References

  1. UBS Group Annual Report 2025ubs.com
  2. UBS Global Researchubs.com
  3. UBS Equity Research Rating System definitionsresearch.ibb.ubs.com
  4. UBS history: 1862-1872ubs.com
  5. UBS-ARC Unlocks New Investment Insights and Access into APAC (Jan 2026)ubs.com
  6. Reuters: UBS CEO Ermotti may stay late into 2027 (Apr 2026)reuters.com